glutathione s transferase mu antibody S-transferase 2 inhibits hepatic steatosis via ASK1 suppression Human Glutathione S‑Transferase mu 1/GSTM1

Some compounded products also appear in oral troches or capsules, though injection remains the preferred route due to higher bioavailability

While much of the research remains in preclinical stages, early findings are promising

Other established ED treatments include: Vacuum erection devices Intracavernosal injections (alprostadil) Intraurethral alprostadil Testosterone replacement (for confirmed hypogonadism) Psychosexual therapy Penile prosthesis surgery (for refractory cases) All of these options have defined roles in ED management and are supported by clinical evidence

The public use files for CY 2025 are available on the CMS website under downloads for the CY 2025 PFS proposed rule at